P
Philip C. Calder
Researcher at University of Southampton
Publications - 808
Citations - 70822
Philip C. Calder is an academic researcher from University of Southampton. The author has contributed to research in topics: Polyunsaturated fatty acid & Eicosapentaenoic acid. The author has an hindex of 125, co-authored 747 publications receiving 59110 citations. Previous affiliations of Philip C. Calder include Southampton General Hospital & Radboud University Nijmegen Medical Centre.
Papers
More filters
Journal ArticleDOI
The British Journal of Nutrition , an international journal that continues to develop
Journal ArticleDOI
Symposium on ’Nutrition in the post-genomic era’ Plenary session 4: Genetic variation and diet-related disease
TL;DR: Un travail re´cent dans notre laboratoire indique que les polymorphismes de the cytokine peuvent influencer la susceptibilite´ a` certains cancers (ainsi que son pronostic), entre eux le me´lanome de peau maligne dans une maladie ce´liaque existante.
Journal ArticleDOI
Plant and Marine Derived (n-3) Polyunsaturated Fatty Acids Do Not Affect Blood Coagulation and Fibrinolytic Factors in Moderately Hyperlipidemic Humans
Yvonne E. Finnegan,D. J. Howarth,Anne Marie Minihane,Samantha Kew,George J. Miller,Philip C. Calder,Christine M. Williams +6 more
TL;DR: Long-term supplementation with either dietary EPA+DHA or estimated biologically equivalent amounts of ALA did not affect factors VIIa, VIIc, VIIag, XIIa, XIIag, fibrinogen concentrations, plasminogen activator inhibitor-1 or tissue plasminegen activator activity compared with the control.
Journal ArticleDOI
Dietary arachidonic acid: harmful, harmless or helpful?
TL;DR: The first study of increased dietary intake of arachidonic acid in an adult population with high fish intake is assessed; previous studies in healthy adult human subjects have been conducted in low fish consumers in the USA and in the UK.
Journal ArticleDOI
Effect of ω-3 polyunsaturated fatty acids on arthritic pain: A systematic review.
TL;DR: A systematic literature review of ω-3 PUFAs and pain associated with rheumatoid arthritis was performed up to December 2015 as mentioned in this paper, with the aim of investigating the effect of PUFA on arthritic pain.